{
    "ticker": "CDMO",
    "name": "Contract Pharmacal Corp.",
    "description": "Contract Pharmacal Corp. (CDMO) is a leading contract development and manufacturing organization (CDMO) that specializes in providing comprehensive pharmaceutical services to clients in the biopharmaceutical and life sciences sectors. Established in 1981, CDMO has built a strong reputation for its expertise in drug formulation, analytical testing, and manufacturing processes. The company is dedicated to supporting its clients throughout the entire product lifecycle, from early-stage development to commercial production. CDMO offers a wide range of services, including the development of solid dosage forms, sterile injectables, and topical formulations. With state-of-the-art facilities and a commitment to quality, CDMO adheres to stringent regulatory standards, ensuring the safety and efficacy of the products it manufactures. The company's focus on innovation and customer service has enabled it to forge long-lasting partnerships with both emerging and established pharmaceutical companies. CDMO's mission is to enhance patient outcomes by delivering high-quality, reliable pharmaceutical products that meet the unique needs of its clients.",
    "industry": [
        "Pharmaceuticals",
        "Contract Manufacturing"
    ],
    "headquarters": "Hauppauge, New York, USA",
    "founded": "1981",
    "website": "https://www.contractpharmacal.com",
    "ceo": "David A. DeLuca",
    "social_media": {
        "linkedin": "https://www.linkedin.com/company/contract-pharmacal-corp/"
    },
    "investor_relations": "https://www.contractpharmacal.com/investor-relations",
    "key_executives": [
        {
            "name": "David A. DeLuca",
            "position": "CEO"
        },
        {
            "name": "Michael DeLuca",
            "position": "President"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceutical Development",
            "products": [
                "Formulation Development",
                "Analytical Services"
            ]
        },
        {
            "category": "Manufacturing Services",
            "products": [
                "Solid Dosage Forms",
                "Sterile Injectables",
                "Topical Formulations"
            ]
        }
    ],
    "seo": {
        "meta_title": "Contract Pharmacal Corp. | Leading CDMO for Pharmaceutical Services",
        "meta_description": "Explore Contract Pharmacal Corp., a prominent CDMO specializing in pharmaceutical development and manufacturing. Learn about our services and commitment to quality.",
        "keywords": [
            "CDMO",
            "Contract Pharmacal Corp.",
            "Pharmaceutical Manufacturing",
            "Pharmaceutical Development",
            "Biopharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What services does CDMO provide?",
            "answer": "CDMO provides pharmaceutical development and manufacturing services, including formulation development and analytical testing."
        },
        {
            "question": "Who is the CEO of CDMO?",
            "answer": "David A. DeLuca is the CEO of Contract Pharmacal Corp."
        },
        {
            "question": "Where is CDMO headquartered?",
            "answer": "CDMO is headquartered in Hauppauge, New York, USA."
        },
        {
            "question": "What types of products does CDMO manufacture?",
            "answer": "CDMO manufactures solid dosage forms, sterile injectables, and topical formulations."
        },
        {
            "question": "When was CDMO founded?",
            "answer": "CDMO was founded in 1981."
        }
    ],
    "competitors": [
        "PRAH",
        "CAMP",
        "AMRI",
        "PTGX"
    ],
    "related_stocks": [
        "MRK",
        "PFE",
        "JNJ",
        "BMY"
    ]
}